Team introduction
Team introduction
Current position: Home > Boston Office>
Daguang is the managing director of Yonjin Venture, the North America and Europe investment arm of Yongjin Group in Shanghai, China. Before venture investment, Daguang spent more than 20 years in the biotech and pharmaceutical industry with Amgen, Memory Pharmaceuticals, PsychoGenics, EMD Serono and Sanofi. Daguang started his career as a scientist in neuroscience, working in the areas of neurodegenerative diseases and psychiatric disorders, before moving to business development and external innovation with a focus on neuroscience, multiple sclerosis and rare diseases. Daguang was a global lead of business development and external innovation for neuroscience at Sanofi before joining Yonjin Venture in 2018. Daguang serves on the board of multiple biotech companies.
Daguang received his bachelor degree in biochemistry from Jilin University in China, and his PhD in molecular genetics from the Washington University in St Louis in the US. Daguang conducted postdoctoral research at Stanford University with Professor Roger Kornberg.
Qiong is an Investment Manager at Yonjin Venture. Qiong primarily focuses on investment opportunities in pharmaceutical, biotechnology and medical device sectors and actively involves in deal sourcing, due diligence and post-investment management. Qiong has more than 8 years’ academic research experience before moving to venture investment. Prior to joining Yonjin Venture, Qiong worked as a Postdoctoral Research Fellow at Massachusetts General Hospital and Harvard Medical School, where her research focused on understanding the biochemical mechanism of key signaling pathways in embryonic development. Qiong received her Ph.D. in Biochemistry and Molecular Biology from Peking University, China.

Address:1 Broadway, 14th floor Cambridge, MA 02142